{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:48:46Z","timestamp":1774568926720,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.breast.2025.104674","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:06:35Z","timestamp":1765440395000},"page":"104674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7467-453X","authenticated-orcid":false,"given":"Peter H.","family":"Wessels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sten","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Monkhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabe S.","family":"Sonke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annegien","family":"Broeks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothe","family":"Linders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daan","family":"van den Broek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam C.","family":"Boelens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieta","family":"Brandsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2025.104674_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cncr.30911","article-title":"Leptomeningeal metastasis from systemic cancer: review and update on management","volume":"124","author":"Wang","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2025.104674_bib2","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance System","volume":"22","author":"Barnholtz-Sloan","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104674_bib3","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1158\/1078-0432.CCR-06-2478","article-title":"Brain metastases: the HER2 paradigm","volume":"13","author":"Lin","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2025.104674_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-012-0408-4","article-title":"Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival","volume":"30","author":"Niwi\u0144ska","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.breast.2025.104674_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clbc.2016.07.002","article-title":"Characteristics and outcomes of patients with breast cancer with leptomeningeal metastasis","volume":"17","author":"Morikawa","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2025.104674_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.breast.2017.07.015","article-title":"Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: a single-centre experience","volume":"36","author":"Kingston","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.breast.2025.104674_bib7","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.breast.2025.104674_bib8","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/S1470-2045(20)30556-8","article-title":"The genomic landscape of breast cancer brain metastases: a systematic review","volume":"22","author":"Morgan","year":"2021","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.breast.2025.104674_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/onco.13855","article-title":"Clinicopathologic and genomic landscape of breast carcinoma brain metastases","volume":"26","author":"Huang","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.breast.2025.104674_bib10","doi-asserted-by":"crossref","first-page":"7134","DOI":"10.1158\/0008-5472.CAN-13-2051","article-title":"Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis","volume":"73","author":"Magbanua","year":"2013","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.breast.2025.104674_bib11","first-page":"8839 1","article-title":"Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma","volume":"10","author":"Mattos-arruda","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.breast.2025.104674_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41588-018-0287-5","article-title":"Acquired HER2 mutations in ER + metastatic breast cancer confer resistance to estrogen receptor-directed therapies","volume":"51","author":"Nayar","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.breast.2025.104674_bib13","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2016.66.6487","article-title":"Evaluating cancer of the central nervous System through next-generation sequencing of cerebrospinal fluid","volume":"34","author":"Pentsova","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104674_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4048\/jbc.2020.23.e4","article-title":"ESR1 mutation detection and dynamics in meningeal carcinomatosis in breast cancer","volume":"23","author":"Carausu","year":"2020","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.breast.2025.104674_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-023-04261-2","article-title":"A review on genetic alterations in CNS metastases related to breast cancer treatment. Is there a role for liquid biopsies in CSF?","volume":"162","author":"Wessels","year":"2023","journal-title":"J Neuro Oncol"},{"issue":"1","key":"10.1016\/j.breast.2025.104674_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-017-2691-6","article-title":"EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid","volume":"137","author":"van Bussel","year":"2018","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.breast.2025.104674_bib17","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41596-023-00933-5","article-title":"Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice","volume":"19","author":"Samsom","year":"2024","journal-title":"Nat Protoc"},{"key":"10.1016\/j.breast.2025.104674_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: a precision oncology knowledge base","volume":"1","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.breast.2025.104674_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.yexmp.2016.04.002","article-title":"Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers","volume":"100","author":"Muller","year":"2016","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.breast.2025.104674_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz242.013","article-title":"Association between PIK3CA mutation status and development of brain metastases in HR+\/HER2- metastatic breast cancer","volume":"30","author":"Fitzgerald","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2025.104674_bib21","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/bcr3150","article-title":"Relevance of PTEN loss in brain metastasis formation in breast cancer patients","volume":"14","author":"Wikman","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.breast.2025.104674_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/bjc.2011.464","article-title":"High frequency of complex TP53 mutations in CNS metastases from breast cancer","volume":"106","author":"Lo","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2025.104674_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1158\/2159-8290.CD-21-0697","article-title":"Futibatinib, an irreversible FGFR1-4 inhibitor, in patients with advanced solid tumors harboring FGF\/FGFR aberrations: a phase I dose-expansion Study","volume":"12","author":"Meric-Bernstam","year":"2022","journal-title":"Cancer Discov"},{"issue":"12","key":"10.1016\/j.breast.2025.104674_bib24","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/neuonc\/noae138","article-title":"Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of EGFR mutated NSCLC patients developing leptomeningeal metastases: ORA-LM study","volume":"5","author":"van der Wel","year":"2024","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.breast.2025.104674_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz133","article-title":"Targeting the PI3-kinase pathway in triple negative breast cancer","author":"Pascual","year":"2019","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.breast.2025.104674_bib26","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1200\/PO.19.00403","article-title":"Response of brain metastases from PIK3CA -Mutant breast cancer to alpelisib","volume":"27","author":"Batalini","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.breast.2025.104674_bib27","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1200\/JCO.24.00427","article-title":"US food and drug administration approval summary: capivasertib with fulvestrant for hormone receptor-positive, human epidermal growth factor receptor 2-Negative locally advanced or metastatic breast cancer with PIK3CA\/AKT1\/PTEN alterations","volume":"42","author":"Dilawari","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.104674_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01169-0","article-title":"Targeting mutant p53 for cancer therapy: direct and indirect strategies","volume":"14","author":"Hu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.breast.2025.104674_bib29","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/ng.2822","article-title":"ESR1 ligand binding domain mutations in hormone-resistant breast cancer","volume":"45","author":"Toy","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.breast.2025.104674_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-56412-8","article-title":"Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling","volume":"14","author":"De Marchi","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.breast.2025.104674_bib31","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jamaoncol.2016.1279","article-title":"Prevalence of ESR1 mutations in cell-free DNA and outcomes in metastatic breast cancer","volume":"2","author":"Chandarlapaty","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2025.104674_bib32","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1002\/cncr.32345","article-title":"ESR1 mutations in breast cancer","volume":"125","author":"Dustin","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2025.104674_bib33","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1002\/j.1460-2075.1995.tb00301.x","article-title":"E-cadherin is a tumour\/invasion suppressor gene mutated in human lobular breast cancers","volume":"14","author":"Berx","year":"1995","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.breast.2025.104674_bib34","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/1759-7714.13300","article-title":"Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples","volume":"11","author":"Ma","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.breast.2025.104674_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2017-000253","article-title":"Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases","volume":"2","author":"Siravegna","year":"2017","journal-title":"ESMO Open"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625008938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625008938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:07:20Z","timestamp":1770998840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977625008938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":35,"alternative-id":["S0960977625008938"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.104674","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.104674","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104674"}}